Chongqing Zhifei Biological Products Co Ltd Class A 300122
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- ¥24.21
- Day Range
- ¥24.70–28.66
- 52-Week Range
- ¥20.38–70.27
- Bid/Ask
- ¥27.82 / ¥27.83
- Market Cap
- ¥66.60 Bil
- Volume/Avg
- 72.2 Mil / 20.4 Mil
Key Statistics
- Price/Earnings (Normalized)
- 11.23
- Price/Sales
- 1.43
- Dividend Yield (Trailing)
- 2.88%
- Dividend Yield (Forward)
- 2.88%
- Total Yield
- 2.88%
Company Profile
Chongqing Zhifei Biological Products Co Ltd is engaged in research and development, production and sales of vaccines and biological products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Large Value
- Total Number of Employees
- 7,365
- Website
- https://www.zhifeishengwu.com
Comparables
Valuation
|
Metric
|
300122
|
688739
|
301207
|
|---|---|---|---|
Price/Earnings (Normalized) | 11.23 | 28.96 | 15.59 |
Price/Book Value | 2.11 | 1.12 | 1.84 |
Price/Sales | 1.43 | 6.00 | 4.74 |
Price/Cash Flow | 9.26 | 16.98 | 11.51 |
Price/Earnings
300122
688739
301207
Financial Strength
|
Metric
|
300122
|
688739
|
301207
|
|---|---|---|---|
Quick Ratio | 1.37 | 17.26 | 2.85 |
Current Ratio | 2.07 | 18.49 | 3.42 |
Interest Coverage | 76.85 | 288.58 | 149.96 |
Quick Ratio
300122
688739
301207
Profitability
|
Metric
|
300122
|
688739
|
301207
|
|---|---|---|---|
Return on Assets (Normalized) | 11.64% | 3.14% | 9.24% |
Return on Equity (Normalized) | 19.62% | 3.29% | 11.52% |
Return on Invested Capital (Normalized) | 17.67% | 2.81% | 10.82% |
Return on Assets
300122
688739
301207
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Qpzmjpjvxp | Kfqh | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Cztkpkqxm | Hwsgvld | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Qdjrsllwn | Bflxg | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Bycrbxkt | Scrymqm | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Xzfhmblv | Dlwr | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Htwpdvwy | Hjp | $28.1 Bil | |||
| Moderna Inc
MRNA
| Tsgwyhs | Ngb | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Jfwnjsqpw | Qnq | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Bytykwlp | Hrggytz | $13.4 Bil | |||
| Incyte Corp
INCY
| Fmqdcqkv | Kdhtfb | $12.7 Bil |
United States